Georgia woman part of lawsuit claiming link between GLP-1 weight loss drugs and blindness – WSB-TV Channel 2
ATLANTA — A Georgia woman said her GLP-1 weight loss drug made her blind. She said she took…
Strengthening the metabolic alliance: exercise as an essential partner of obesity pharmacotherapy
Competing interests J.B. has received speaking fees from Novo Nordisk and Eli Lilly for educational activities related to…
Researchers Expected Ozempic Weight Loss to Boost Exercise. It Didn’t
A large study found that people taking GLP-1 weight-loss drugs such as Ozempic and Wegovy became less physically…
Night owls who don’t respond to SSRIs: circadian rhythm core to ‘atypical’ depression mystery
About 21% of patients with depression have an atypical form that is less likely to respond to common antidepressants,…
Dulaglutide, semaglutide, and tirzepatide exhibit comparable gastrointestinal adverse event risk
1. In this cohort study, dulaglutide, semaglutide, and tirzepatide demonstrated similar risks of gastrointestinal adverse events (AEs) in…
Diabetes drug blunts exercise-induced health improvements
A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease:…
Nearly half of people with diabetes don’t know they have it, new study finds
When was the last time you had your blood sugar checked? It might be worth looking into, a…
Growth Hormone Benefits Kids With Rare Genetic Condition
TOPLINE: A standard-dose recombinant growth hormone therapy administered for 2 years demonstrated positive effects on both growth and…
High-Dose vitamin D for VLBW infants
Doubling the vitamin D dose for premature, very low birth weight infants can safely give their tiny bones…
New gene editing approach targets mutation behind common genetic heart disease
Fourteen million people worldwide suffer from enlarged hearts, or hypertrophic cardiomyopathy (HCM), a genetic disease that thickens the…